Alexander Hardy

President and CEO

CEO Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Biomarin Pharmaceutical Inc (BMRN)	President and CEO	$1,130,769	—	$16,833,629	$1,909,310	$1,644,500	$409,355	$21,927,563
2024	Biomarin Pharmaceutical Inc (BMRN)	President and CEO —	$1,050,000	—	$10,490,968	$1,661,566	$1,501,500	$149,571	$14,853,605
2023	Biomarin Pharmaceutical Inc (BMRN)	President and CEO —	$64,615	$900,000	$10,662,587	$6,207,816	—	$40,218	$17,875,236

Executive changes

Appointed member of the Board at Biomarin Pharmaceutical Inc (BMRN)
2023-12-01
Appointed President and Chief Executive Officer at Biomarin Pharmaceutical Inc (BMRN)
2023-12-01

Earnings-call appearances

BioMarin Pharmaceutical Second Quarter 2026 Conference Call
Biomarin Pharmaceutical Inc (BMRN)

2026-08-06
Biomarin Pharmaceutical Inc Q1 FY2026 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2026-05-04
Biomarin Pharmaceutical Inc Q4 FY2025 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2026-02-23
Biomarin Pharmaceutical Inc Q3 FY2025 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2025-10-27
Biomarin Pharmaceutical Inc Q2 FY2025 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2025-08-04
Biomarin Pharmaceutical Inc Q1 FY2025 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2025-05-16
Biomarin Pharmaceutical Inc Q4 FY2024 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2025-02-19
Biomarin Pharmaceutical Inc Q3 FY2024 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2024-10-29
Biomarin Pharmaceutical Inc Q2 FY2024 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2024-08-05
Biomarin Pharmaceutical Inc Q1 FY2024 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2024-04-24
Biomarin Pharmaceutical Inc Q4 FY2023 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2024-02-22